Efficacy of standard anticonvulsants in monkey model with spontaneous motor seizures.
Monkeys were rendered chronically epileptic by injection of alumina gel into the pre- and postcentral gyrus. To test the validity of this primate model, the effects of diphenylhydantoin (DPH), phenobarbital, and primidone on spontaneous seizures evaluated for 8 months with a Latin-Squar experimental design. All three drugs were effective, the frequency of seizures being reduced by at least one-half during 6 weeks with treatment as compared with 6 weeks without. In most monkeys the frequency and severity of seizures were correlated to the number of interictal spikes in the EEG, and were inversely related to the level of drug in plasma. During withdrawal of phenobarbital and primidone, epileptic activity increased over that during control periods. Side effects were minimal with all three drugs. Patterns of behavior, although they differed from one monkey to the next, exhibited trends specific to each drug but particularly DPH. The seizures of some animals seemed to be related to the sleep-waking cycle.
D000535:Aluminum; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004569:Electroencephalography; D005247:Feeding Behavior / Q000187:drug effects; D006801:Humans; D008251:Macaca; D008297:Male; D009044:Motor Cortex / Q000503:physiopathology; D010634:Phenobarbital / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D010672:Phenytoin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D011324:Primidone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D011930:Reaction Time / Q000187:drug effects; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome
D000927:Anticonvulsants; D011324:Primidone; D010672:Phenytoin; D000535:Aluminum; D010634:Phenobarbital